These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24167935)

  • 1. [Elite controllers and the mechanisms behind spontaneous control of HIV].
    Shasha D
    Harefuah; 2013 Aug; 152(8):481-5, 498. PubMed ID: 24167935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: mechanisms of HIV elite control in two African women.
    Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA
    BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.
    Salgado M; Swanson MD; Pohlmeyer CW; Buckheit RW; Wu J; Archin NM; Williams TM; Margolis DM; Siliciano RF; Garcia JV; Blankson JN
    J Virol; 2014 Mar; 88(6):3340-52. PubMed ID: 24390323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the elite: mechanisms of control in HIV-1 infection.
    O'Connell KA; Bailey JR; Blankson JN
    Trends Pharmacol Sci; 2009 Dec; 30(12):631-7. PubMed ID: 19837464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells.
    Descours B; Avettand-Fenoel V; Blanc C; Samri A; Mélard A; Supervie V; Theodorou I; Carcelain G; Rouzioux C; Autran B;
    Clin Infect Dis; 2012 May; 54(10):1495-503. PubMed ID: 22441653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood.
    Hocini H; Bonnabau H; Lacabaratz C; Lefebvre C; Tisserand P; Foucat E; Lelièvre JD; Lambotte O; Saez-Cirion A; Versmisse P; Thiébaut R; Lévy Y
    J Virol; 2019 May; 93(10):. PubMed ID: 30814287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.
    Goujard C; Girault I; Rouzioux C; Lécuroux C; Deveau C; Chaix ML; Jacomet C; Talamali A; Delfraissy JF; Venet A; Meyer L; Sinet M;
    Antivir Ther; 2012; 17(6):1001-9. PubMed ID: 22865544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection.
    Musey L; Hughes J; Schacker T; Shea T; Corey L; McElrath MJ
    N Engl J Med; 1997 Oct; 337(18):1267-74. PubMed ID: 9345075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elite control of HIV infection: implications for vaccine design.
    Baker BM; Block BL; Rothchild AC; Walker BD
    Expert Opin Biol Ther; 2009 Jan; 9(1):55-69. PubMed ID: 19063693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1.
    Bello G; Velasco-de-Castro CA; Bongertz V; Rodrigues CA; Giacoia-Gripp CB; Pilotto JH; Grinsztejn B; Veloso VG; Morgado MG
    J Med Virol; 2009 Oct; 81(10):1681-90. PubMed ID: 19697415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4(+) T helper cells and the role they play in viral control.
    Norris PJ; Rosenberg ES
    J Mol Med (Berl); 2002 Jul; 80(7):397-405. PubMed ID: 12110945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART.
    López M; Soriano V; Peris-Pertusa A; Rallón N; Restrepo C; Benito JM
    AIDS Res Hum Retroviruses; 2011 Feb; 27(2):157-65. PubMed ID: 20964478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV controllers: how do they tame the virus?
    Sáez-Cirión A; Pancino G; Sinet M; Venet A; Lambotte O;
    Trends Immunol; 2007 Dec; 28(12):532-40. PubMed ID: 17981085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load.
    Harrer T; Harrer E; Kalams SA; Barbosa P; Trocha A; Johnson RP; Elbeik T; Feinberg MB; Buchbinder SP; Walker BD
    J Immunol; 1996 Apr; 156(7):2616-23. PubMed ID: 8786327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection.
    Vieillard V; Costagliola D; Simon A; Debré P;
    AIDS; 2006 Sep; 20(14):1795-804. PubMed ID: 16954720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of the pool of infected resting CD4 HLA-DR- T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection.
    Sankatsing SU; van Praag RM; van Rij RP; Rientsma R; Jurriaans S; Lange JM; Prins JM; Schuitemaker H
    Antivir Ther; 2003 Apr; 8(2):137-42. PubMed ID: 12741626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV controllers: how these patients control viral replication?].
    Lambotte O
    Med Sci (Paris); 2012 Feb; 28(2):172-8. PubMed ID: 22377305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy.
    Guihot A; Tubiana R; Breton G; Marcelin AG; Samri A; Assoumou L; Goncalves E; Bricaire F; Costagliola D; Calvez V; Rouzioux C; Autran B; Katlama C; Carcelain G; ;
    AIDS; 2010 Feb; 24(4):614-7. PubMed ID: 19952710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.